Factors Affecting Drug Prescription in Patients With Stable COPD: Results From a Multicenter Spanish Study

de Miguel Díez, J.; Izquierdo Alonso, J.L.; Molina París, J.; Bellón Cano, J.M.; Rodríguez González-Moro, J.M.; de Lucas Ramos, P.

doi:10.1016/S1579-2129(06)60399-6

Archivos de Bronconeumología

ISSN: 0300-2896

Archivos de Bronconeumologia is an international journal that publishes original studies whose content is based upon results of research initiatives dealing with several aspects of respiratory medicine including epidemiology, respiratory physiology, pathophysiology of respiratory diseases, clinical management, thoracic surgery, pediatric lung diseases, respiratory critical care, respiratory allergy and translational research. Other types of articles such as editorials, reviews, and different types of letters are also published in the journal. Additionally, the journal expresses the voice of the following scientific societies: the Spanish Respiratory Society of Pneumology and Thoracic Surgery (SEPAR; https://www.separ.es/), the Latin American Thoracic Society (ALAT; https://alatorax.org/), and the Iberian American Association of Thoracic Surgery (AIACT; http://www.aiatorax.com/).

It is a monthly journal in which all manuscripts are sent to peer-review and handled by the editor or an associate editor from the team and the final decision is made on the basis of the comments from the expert reviewers and the editors. The journal is published solely in English. All the published data is composed of novel manuscripts not previously published in any other journal and not being in consideration for publication in any other journal..

The journal is indexed at Science Citation Index Expanded, Medline/Pubmed, Embase and SCOPUS. Access to any published article is possible through the journal's web page as well as from Pubmed, ScienceDirect, and other international databases. Furthermore, the journal is also present in X, Facebook and Linkedin. Manuscripts can be submitted electronically using the following web site: https://www.editorialmanager.com/ARBR/.

Indexed in:

Current Contents/Clinical Medicine, JCR SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, SCOPUS, IBECS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

8.7

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

3.5

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.464

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.482

View more metrics

Open Access Option

Journal Information

Previous article | Next article

Vol. 41. Issue 2.

Pages 63-70 (February 2005)

More article options

Pages 63-70 (February 2005)

Original Articles

DOI: 10.1016/S1579-2129(06)60399-6

Full text access

Factors Affecting Drug Prescription in Patients With Stable COPD: Results From a Multicenter Spanish Study

Visits

4184

Download PDF

J. de Miguel Díeza, J.L. Izquierdo Alonsob,

Corresponding author

jlizquierdo@sescam.org

Correspondence: Dr. J.L. Izquierdo Alonso. Sección de Neumología. Hospital General Universitario de Guadalajara. Donantes de Sangre, s/n. 19002 Guadalajara. España

, J. Molina Parísc, J.M. Bellón Canod, J.M. Rodríguez González-Moroa, P. de Lucas Ramosa

a Servicio de Neumología, Hospital General Universitario Gregorio Marañón, Madrid, Spain

b Servicio de Neumología, Hospital General Universitario de Guadalajara, Guadalajara, Spain

c Centro de Salud Francia, Fuenlabrada, Madrid, Spain

d Unidad de Investigación, Hospital General Universitario Gregorio Marañón, Madrid, Spain

This item has received

4184 Visits

Article information

Statistics

Objective

TO determine what factors are associated with prescription of drugs to patients with stable chronic obstructive pulmonary disease (COPD).

Material and Methods

We studied 568 patients with stable COPD. Assessments included determination of the severity of dyspnea, body mass index, health-related quality of life, and spirometry testing.

Results

The forced expiratory volume in 1 second was significantly associated with prescription of long-acting β2-adrenergic agonists (odds ratio [OR]=0.98; 95% confidence interval [CI], 0.96-1) and inhaled corticosteroids (OR=0.98; 95% CI, 0.96-1). Quality of life was related to administration of short-acting β2-adrenergic agonists (OR=1.02; 95% CI, 1-1.03), long-acting β2-adrenergic agonists (OR=1.02; 95% CI, 1-1.03), ipratropium bromide (OR=1.03; 95% CI, 1-1.04), theophylline drugs (OR=1.02; 95% CI, 1-1.03), and inhaled corticosteroids (OR=1.02; 95% CI, 1-1.03). The severity of dyspnea was significantly associated with prescription of oral corticosteroids (for grade IV dyspnea, OR=15.25; 95% CI, 2.40-97.02). Body mass index was not related to drug administration.

Conclusions

Drug prescription in patients with stable COPD correlates not only with forced expiratory volume in 1 second but also with other parameters such as health-related quality of life and dyspnea.

Factores determinantes de la prescripción farmacológica en los pacientes con EPOC estable. Resultados de un estudio multicéntrico español (IDENTEPOC)

Key Words:

COPD

FEV1

Health-related quality of life

Dyspnea

Treatment

Objetivo

Determinar qué factores se relacionan con la prescripción de fármacos en los pacientes con enfermedad pulmonar obstructiva crónica (EPOC) estable.

Material Y Métodos

Se estudió a 568 pacientes con EPOC estable. La evaluación realizada incluyó la medición del grado de disnea, la determinación del índice de masa corporal, el estudio de la calidad de vida relacionada con la salud y la realización de una espirometría.

Resultados

El volumen espiratorio forzado en el primer segundo se asoció significativamente con la prescripción de β2-adrenérgicos de acción larga (odds ratio [OR] = 0,98; in-tervalo de confianza [IC] del 95%, 0,96-1) y corticoides in-halados (OR = 0,98; IC del 95%, 0,96-1). La calidad de vida se relacionó con la administración de β2-adrenérgicos de acción corta (OR = 1,02; IC del 95%, 1-1,03), β2-adrenérgicos de acción larga (OR = 1,02; IC del 95%, 1-1,03), bromuro de ipratropio (OR = 1,03; IC del 95%, 1-1,04), teofilinas (OR = 1,02; IC del 95%, 1-1,03) y corticoides inhalados (OR = 1,02; IC del 95%, 1-1,03). El grado de disnea mostró una asociación significativa con la prescripción de corticoides orales (para disnea grado IV, OR = 15,25; IC del 95%, 2,40-97,02). No se encontró ninguna relación entre la administración de fármacos y el índice de masa corporal.

Conclusiones

La prescripción farmacológica de los pacientes con EPOC estable viene determinada no sólo por el volumen espiratorio forzado en el primer segundo, sino tam-bién por otros parámetros, entre los que se incluyen la calidad de vida relacionada con la salud y la disnea.

Palabras clave:

EPOC

FEV1

Calidad de vida relacionada con la salud

Disnea

Tratamiento

Full text is only aviable in PDF

REFERENCES

[1]

JA Barberà, G Peces-Barba, AGN Agustí, JL Izquierdo, E Monsó, T Montemayor, et al.

Guía clínica para el diagnóstico y el tratamiento de la enfermedad pulmonar obstructiva crónica.

Arch Bronconeumol., 37 (2001), pp. 297-316

Indexed in:

Follow us:

Subscribe:

Subscribe to our newsletter